Inhibition of c-Kit by tyrosine kinase inhibitors. [electronic resource]
Producer: 20150930Description: e77-9 p. digitalISSN:- 1592-8721
- Aminopyridines -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Benzothiazoles -- therapeutic use
- Biomarkers -- analysis
- Bone Marrow -- drug effects
- Cell Line, Tumor
- Clinical Trials as Topic
- Dasatinib
- Gene Expression
- Hair -- drug effects
- Hematopoietic Stem Cells -- drug effects
- Humans
- Indazoles
- Leukemia, Myeloid, Acute -- drug therapy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Pigmentation -- drug effects
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins c-kit -- antagonists & inhibitors
- Pyrimidines -- therapeutic use
- Pyrroles -- therapeutic use
- Sorafenib
- Sulfonamides -- therapeutic use
- Thiazoles -- therapeutic use
- fms-Like Tyrosine Kinase 3 -- antagonists & inhibitors
No physical items for this record
Publication Type: Letter; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.